Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 2252-2256, July 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imai, K.
Right arrow Articles by Ferrone, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imai, K.
Right arrow Articles by Ferrone, S.

Indirect Rosette Microassay to Characterize Human Melanoma-associated Antigens Recognized by Operationally Specific Xenoantisera1

Kohzoh Imai2 and Soldano Ferrone3

Department of Molecular Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037

The indirect rosette assay which detects the interaction of antibodies with target cells by their ability to rosette with sheep red blood cells chemically coated with purified anti-immunoglobulin antibodies or with protein A from Staphylococcus aureus has been used to analyze xenoantisera to human melanoma-associated antigens. The test has been developed as a microassay and performed in microtiter plates, thus facilitating the screening of large numbers of samples. When modified as an inhibition assay, the assay has been successfully used (a) to compare the specificities of xenoantisera elicited with cultured melanoma cells, hybrids derived from the fusion of cultured human melanoma cells, and murine fibroblasts and melanoma-associated antigens purified by biochemical procedures and (b) to investigate the relationship of melanoma-associated antigens with ß2-microglobulin and HLA antigens on the membrane of melanoma cells.

1 This work was supported by USPHS grants. This is Publication 1989 from Scripps Clinic and Research Foundation.

2 Visiting investigator from Sapporo Medical College (Japan) and recipient of a USPHS International Research Fellowship (1 F05 TW02817-01). To whom requests for reprints should be addressed.

3 Recipient of an American Heart Association Established Investigatorship Award.

Received 12/ 3/79. Accepted 4/10/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.